Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
NEW YORK, April 06, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Rockwell Medical, Inc. (NASDAQ:RMTI) securities between September 9, 2015 and February 29, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/rockwell-medical. There is no cost or obligation to you.
The complaint alleges that the Company failed to disclose that: (1) Rockwell’s main product offering for Triferic has not yet been approved by the FDA; and (2) Rockwell is seeking to obtain transitional add-on payment reimbursement for Triferic with the Centers for Medicare & Medicaid Services instead of bundled reimbursement.
If you suffered a loss in Rockwell Medical you have until May 3, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/rockwell-medical.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
